Snowden Capital Advisors LLC Purchases Shares of 8,089 Henry Schein, Inc. (NASDAQ:HSIC)

Snowden Capital Advisors LLC acquired a new position in shares of Henry Schein, Inc. (NASDAQ:HSIC) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 8,089 shares of the company’s stock, valued at approximately $560,000.

Other hedge funds also recently bought and sold shares of the company. Venturi Wealth Management LLC lifted its stake in Henry Schein by 3,347.1% during the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock valued at $41,000 after buying an additional 569 shares in the last quarter. Quent Capital LLC lifted its stake in Henry Schein by 91.2% during the fourth quarter. Quent Capital LLC now owns 677 shares of the company’s stock valued at $47,000 after buying an additional 323 shares in the last quarter. Smartleaf Asset Management LLC lifted its stake in Henry Schein by 23.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock valued at $52,000 after buying an additional 143 shares in the last quarter. Allworth Financial LP lifted its stake in Henry Schein by 180.7% during the fourth quarter. Allworth Financial LP now owns 946 shares of the company’s stock valued at $71,000 after buying an additional 609 shares in the last quarter. Finally, Canada Post Corp Registered Pension Plan purchased a new stake in Henry Schein during the fourth quarter valued at about $95,000. 96.62% of the stock is owned by hedge funds and other institutional investors.

Henry Schein Trading Up 1.8%

Shares of Henry Schein stock opened at $73.13 on Wednesday. The company’s fifty day simple moving average is $67.44 and its 200-day simple moving average is $71.49. The company has a market cap of $8.90 billion, a price-to-earnings ratio of 30.09, a PEG ratio of 2.13 and a beta of 0.87. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a 1 year low of $60.56 and a 1 year high of $82.49.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Monday, May 5th. The company reported $1.15 EPS for the quarter, topping the consensus estimate of $1.11 by $0.04. The firm had revenue of $3.17 billion during the quarter, compared to analysts’ expectations of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. Henry Schein’s quarterly revenue was down .1% compared to the same quarter last year. During the same period last year, the business earned $1.10 earnings per share. As a group, sell-side analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current year.

Analyst Upgrades and Downgrades

A number of analysts have commented on HSIC shares. Barrington Research reduced their price objective on shares of Henry Schein from $90.00 to $86.00 and set an “outperform” rating for the company in a research note on Tuesday, May 6th. Jefferies Financial Group upped their price objective on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research note on Thursday, January 23rd. Piper Sandler dropped their target price on Henry Schein from $83.00 to $77.00 and set an “overweight” rating on the stock in a report on Wednesday, April 30th. UBS Group dropped their target price on Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a report on Wednesday, February 26th. Finally, StockNews.com downgraded Henry Schein from a “buy” rating to a “hold” rating in a report on Thursday, April 17th. Six analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $79.30.

Insider Buying and Selling at Henry Schein

In other news, CEO Bradford C. Connett sold 4,036 shares of the firm’s stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the sale, the chief executive officer now directly owns 62,688 shares in the company, valued at approximately $4,460,251.20. This trade represents a 6.05% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Philip A. Laskawy sold 2,604 shares of the firm’s stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the sale, the director now owns 24,805 shares of the company’s stock, valued at approximately $1,762,147.20. This trade represents a 9.50% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.08% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.